Filippo Pietrantonio
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 404 publications
Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.
Journal: ESMO gastrointestinal oncology
Published: August 28, 2026
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 03, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
Journal: The New England journal of medicine
Published: June 01, 2026
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer.
Journal: The New England journal of medicine
Published: May 27, 2026
Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Journal: Cancer treatment reviews
Published: May 04, 2026
Chemoimmunotherapy enables adaptive strategies in locally advanced MSS colorectal cancer.
Journal: Med (New York, N.Y.)
Published: April 27, 2026
Rarity within rarity: complete response to chemoimmunotherapy in a patient with polymerase epsilon (POLE)-mutated locally advanced jejunal carcinoma.
Journal: The oncologist
Published: April 23, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 21, 2026
Durable Responses to Immunotherapy in dMMR/MSI-H Metastatic Colorectal Cancer Patients With Poor Performance Status.
Journal: Clinical colorectal cancer
Published: April 20, 2026
Highlights in oesophagogastric cancers from ESMO congress 2025.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Last Updated: 09/26/2026